Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia

Journal of Surgical Research

Volumn 69, Issue 1, 1997, Pages 128-134

  Fulton, Gregory J ^a   Barber, Lizzie ^a   Svendsen, Einar ^b   Hagen, Per Otto ^a   Davies, Mark G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DERIVATIVE; GUANINE NUCLEOTIDE BINDING PROTEIN; LIMONENE; NORADRENALIN; PERILLALDEHYDE; PROTEIN P21; RAS PROTEIN; SEROTONIN; TERPENE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; BYPASS SURGERY; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GRAFT PATENCY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; VEIN BYPASS; VEIN GRAFT;

EID: 0031127358     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5047     Document Type: Conference Paper

References (26)

1. 1. Davies, M. G., and Hagen, P-O. Pathophysiology of vein graft failure. Eur. J. Vasc. Endovasc. Surg. 9: 7, 1995.
2. 2. Bandyk, D. F., and Mills, J. L. The failing graft: Detection and management. Semin. Vasc. Surg. 6: 75, 1993.
3. 3. Mannick, J. A. Improved limb salvage from modern infrainguinal artery bypass techniques. Surgery 111: 361, 1992.
4. 4. Crowell, P. L., Chang, R. R., Ren, Z., Elson, C. E., and Gould, M. N. Selective inhibition of isoprenylatioon of 21 and 26 kDa proteins by anticarcinogen D-limonene and its metabolites. J. Biol. Chem. 266: 176, 1991.
5. 5. Schultz, S., Buhling, F., and Ansorge, S. Prenylated proteins and lymphocyte proliferation: Inhibition by D-limonene related monoterpenes. Eur. J. Immunol. 24: 301, 1994.
6. 6. Crowell, P. L., Ren, Z., Lin, S., Vedejs, E., and Gould, M. N. Structural activity relationships among novel monoterpene inhibitrs of small G-protein isoprenylation and cell proliferation. Biochem. Pharmacol. 47: 1405, 1994.
7. 7. Crowell, P. L., Lin, S., Vedejs, E., and Gould, M. N. Identification of metabolites of the antitumor agent D-limonene capable of inhibiting protein isoprenylation and cell growth. Cancer Chemother. Pharmacol. 21: 205, 1992.
8. 8. Igimi, H., Nishimura, M., Kodama, R., and Ide, H. Studies on the metabolism of D-limonene (p-mentha-1,8-diene). I: The absorption, distribution and excretion of D-limonene in rats. Xenobiotica 4: 77, 1974.
9. 9. Davies, M. G., Barber, L., Dalen, H., Svendsen, E., and Hagen, P-O. Pharmacologic control of the structural and functional consequences of vein graft intimal hyperplasia by a 21-aminosteroid (U74389G). Eur. J. Vasc. Surg. 8: 156, 1994.
10. 10. Kolpakov, V., Gordon, D., and Kulik, T. J. Nitric oxide generating coompounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ. Res. 76: 305, 1995.
11. 11. Kulik, T. J., and Alvarado, S. P. Effect of growth and collagen synthesis in cultured rat and lamb pulmonary arterial smooth muscle cells. J. Cell. Physiol. 157: 615, 1993.
12. 12. Davies, M. G., and Hagen, P-O. Pathobiology of intimal hyperplasia. Br. J. Surg. 81: 1254, 1994.
13. 13. Chervu, A., and Moore, W. S. An overview of intimal hyperplasia. Surg. Gynecol Obstet. 171: 433, 1990.
14. 14. Ip, J. H., Fuster, V., Badimon, L., Taubman, M. B., and Chesebro, J. H. Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation. J. Am. Coll. Cardiol. 15: 1667, 1990.
15. 15. Sayers, R. D., Jones, L., Varty, K, et al. The histopathology of infrainguinal vein graft stenoses. Eur. J. Vasc. Surg. 7: 16, 1993.
16. 16. Berkowitz, H. D., Fox, A. D., and Deaton, D. H. Reversed vein graft stenosis: Early diagnosis and management. J. Vasc. Surg. 15: 130, 1992.
17. 17. Davies, M. G., Dalen, H., Barber, E., et al. Suppression of intimal hyperplasia in experimental vein grafts by oral L-arginine supplementation and single ex-vivo immersion in desferrioxamine manganese. J. Vasc. Surg. 23: 410, 1996.
18. 18. Davies, M. G, Barber, E., Dalen, H., Svendsen, E., and Hagen, P-O. Lazaroid therapy (methyl-aminochroman: U83836E) reduces experimental vein graft intimal hyperplasia. J. Surg. Res. 63: 128, 1996.
19. 19. Davies, M. G., Fulton, G. J., Barber, E., Dalen, H., Svendsen, E., and Hagen, P-O. Suppression of angiotensin II responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809. Eur. J. Vasc. Endovasc. Surg. 12: 151, 1996.
20. 20. Lange-Carter, C. A., Pleiman, C. M., Gardner, A. M., Blumer, K. J., and Johnson, G. L. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 260: 315, 1993.
21. 21. Fantl, W. J., Johnson, D. E., and Williams, L. T. Signalling by receptor tryosine kinases. Ann. Rev. Biochem. 62: 453, 1993.
22. 22. Gilman, A. G. G-proteins: Transducers of receptor-generated signals. Ann. Rev. Biochem. 56: 615, 1987.
23. 23. Robinshaw, J. D., and Foster, K. A. Role of G-proteins in the regulation of the cardiovascular system. Ann. Rev. Physiol. 51: 229, 1989.
24. CT reduces intimal hyperplasia formation in experimental vein grafts. Surg. Forum XLVII: 341, 1996.
25. 25. Davies, M. G., Ramkumar, V., Gettys, T., and Hagen, P-O. The expression and function of G-proteins in experimental vein grafts. J. Clin. Invest. 94: 1680, 1994.
26. 26. Shimokawa, H., Flavahan, H. A., and Vanhoutte, P. M. Natural course of the impairment of endothelium dependent relaxation after endothelium removal in porcine arteries: Possible dysfunction of a pertussis toxin sensitive G-protein. Circ. Res. 65: 740, 1989.